Aurinia Pharmaceuticals Inc (AUPH)

EBITDA Margin

60.42%

TTM · Period ending:

AUPH logo

AUPH EBITDA Margin

Latest reported60.42%
AUPH TTM EBITDA Margin (-75.27% → 60.42%)
High-resolution chart · PNG

AUPH ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
60.4211%
54.2366%
50.2743%
38.5304%
33.2543%
26.6402%
13.4936%
1.9922%
-11.1079%
-21.8769%
-35.9216%
-42.72%
-42.8443%
-62.6078%
-77.3304%
-85.7231%
-173.9017%
-247.7758%
-389.5625%
-215.0185%
-256.6284%
-251.0215%
-205.0062%
-144,595.7265%
-45,855.3459%
-42,433.9623%
-38,400.9434%
-19,004.0881%
-12,905.6156%
-12,865.4428%
-13,525.9179%
-13,035.4839%
-47,150.4202%
-12,048.6874%
-10,859.0476%
-9,778.043%
-7,736.342%
-18,420.4082%
-12,332.3699%
-11,111%
-10,260.177%
-10,734.7826%
-10,811.9149%
-8,686.9919%
-7,338.3142%
-6,461.9048%
-5,685.9712%
-1,339.1089%
-1,237.8834%
-863.0265%
-562.9979%
-2,795.4033%
-2,321.8584%
-2,526.7847%
-138.1431%
-16.1128%
-5.9191%
97.2541%
542.3795%
39.9665%
19.605%
-244.7887%
-126.0033%
-72.041%
-70.8326%
-127.1796%
-199.6686%
-313.3181%
-224.7508%
-301.6773%
-368.3744%
-497.7509%
-1,154.0473%
-1,414.5559%
-1,470.986%
-1,332.858%
-1,281.862%
-907.8781%
-644.7991%
-1,500.8496%
-874.5669%
-1,200.1559%
-2,503.4169%
-1,100.3532%
-2,664.2863%
-2,238.3655%
-1,652.2806%
-1,082.0623%
-907.9211%
-120.8451%
-124.2958%
-102.3831%
-16.5099%
-14.3142%
-6.0656%
-2.0673%
-60.7752%
-270.5692%
-571.1291%
-615.7683%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.